Approximately 0.5-2% of the general population are trans and gender diverse, yet trans people are arguably the most marginalised and socioeconomically disadvantaged group in Australia with high rates of depression, suicidality and a dearth of research to guide optimal gender-affirming hormone and surgical interventions. In addition to these barriers, trans people have difficulty accessing basic healthcare due to lack of acceptance and knowledge among healthcare professionals.
A/Prof Cheung will provide an overview of her co-created research in transgender health, the impact of gender affirming hormone therapy on pelvic pain, fertility and bone health. She will also discuss the role that reproductive health clinicians and scientists play in providing affirming care and the similarities and challenges in reproductive and transgender health.